Sunday , July 3 2022

Pouring can be stopped by lighting the skin on the skin – Scientists


Soon, millions of people could get relief by sticking light on the skin, by scientists.

He showed tests on rats that were no longer experiencing the tired feeling after having the procedure – and scratched them less.

The results, which have been branded and exciting, give new hope to those who experience chronic skin disorders such as eczema and psoriasis.

Itchy skin is a great symptom that many patients fight in the conditions would describe such a confusing or even aggravating life.

However, route scratching relief will only be temporarily conditional, as it can cause further skin damage, creating a vicious circle.

The current treatment options for relieving itchy skin depend most often on the control of barrier and inflammation of skin with creams and moisturizers.

This does not target the hole itself, and the chronic driving drive at cellular level is not fully understood – despite years of research.

Researchers at the European Molecular Biology Laboratory in Rome indicated to target the root cause of the war, hoping for new treatment.

A chemical, of the IL31-IR700, which is sensitive to lightweight and binding sensitive cells in the skin's face was developed.

The team spray this chemical into the skin of mice. When the skin that has been treated with a chemical is illuminated with an intimate infrared light, the sensible cells remove from the skin's surface, the tests showed.

This was the scratching idea at the stop off, the researchers wrote in the report published in the journal Nature Biofedical Engineering.

Dr Paul Heppenstall, co-author of study, told MailOnline: The infrared light stimulates a molecule of the name of a photographer who can prepare anything close to it.

And, as a result, when the photographer is on the surface of the neurons, he clips off their limits so they can not find more time.

The process is called photodynamic therapy and was originally developed to kill cancer cells.

By choosing it in the skin in a very familiar way, we can remove selectively from the neurons that cause the rotation – similar to the performance of microbiology using light. & # 39;

For the ease of researchers, led by Dr Linda Nocchi, the method worked well in mice with eczema.

They also found that it also benefited from the rabies with rare genetic skin disease, and currently there is no cure – amyloidosis at present.

Amyloidosis describes a group of rare conditions that occur when a substance of the amyloid name accumulates in the organs.

It can affect a list of organs including the heart, kidneys and liver. However, hedgeous amyloidosis affects the skin in a similar way to eczema.

The mild treatment did not affect other types of nerve cells in the skin that allow you to feel feelings such as pain, vibration, cold or heat.

The effect of the treatment lasted for months, suggesting that this could be a long-term problem for people who are struggling to find treatments.

For me, the most exciting part of this project was to see the improvements in animal health, says Dr Nocchi.

Their skin looked much better after treatment and scratched less. The researchers are now planning on people's testing.

Dr Heppenstall said: We hope one day, our approach will not be able to help people suffering from disease such as eczema, which cause chronic digestion.

Because the team would have to prove what the long-term effects would be, for efficiency and safety, treatment for people would not be available for at least ten years, says Dr Heppenstall.

In April, the same group of researchers announced a method of managing chronic pain with light in a similar way.

The team sprays the skin area affected by the chemical and illuminated with infrared light. Targeted nervous cells are removed from the surface of the skin, resulting in pain relief.

And we believe that the found mechanism could be a general way to control skin sensation, & # 39; says Dr Heppenstall.

Across the world, around 20 per cent of children and up to three per cent of the adult population are some type of eczema.

Our goal now is to take these therapies further. We want to work with industry partners to develop therapies for people, but also for veterinary medication, as it is a big problem in dogs too. & # 39;

Click here for the latest political news

Source link